However, clinico-pathological parameters, including stage, differentiation, amount of ascites, and serum levels of CA125, did not show any correlation to mRNA expression of any given-type ST. Our results suggest that altered mRNA expressions of alpha2,3-sialyltransferase ST3Gal I, ST3Gal III, ST3Gal IV, ST3Gal VI, andalpha2,6-sialyltransferase ST6Gal I are of importance in malignant ovarian cancers.
C0003962
Ascites